RCUS

Stats

Summary

arcus biosciences is an exciting young company founded on a vision of creating new cancer therapeutics through the utilization of emerging insights in immunology. arcus was formed in 2015 by a group of seasoned researchers from the biotechnology and pharmaceutical industries and is located in the san francisco bay area, in the heart of the world’s largest biotechnology research hub. unlike many other organizations, we view the drug discovery process as one that requires equal parts of technology and art, science and elegance, not as a commodity that can be outsourced. for this reason, we have assembled and are continuing to build an internal team of uniquely qualified individuals with extraordinary knowledge, skills and drive. arcus is rapidly establishing a portfolio of novel therapeutics encompassing both small molecules and biologics that target various facets of the immune system implicated in pathology or modulation of the cellular processes of cancer. these new drugs will then be

Market Cap: 1.76 Billion

Primary Exchange: NEW YORK STOCK EXCHANGE INC.

Website: arcusbio.com

Shares Outstanding: 90.9 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.5458261653154541

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 2073 trading days

From: 2018-03-21 To: 2020-03-03

Lowest Point: